查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1508659

病患自控鎮痛幫浦市場:全球產業分析，規模，佔有率，成長，趨勢，預測，2024年～2033年

Patient-controlled Analgesic Pumps Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2033
出版日期: | 出版商: Persistence Market Research | 英文 250 Pages | 商品交期: 2-5個工作天內

價格
簡介目錄

Persistence Market Research最近發布了一份關於病患自控鎮痛幫浦市場的綜合報告。該報告全面評估了主要市場動態，包括市場驅動因素、趨勢、機會和課題，並提供了有關市場結構的詳細見解。

關鍵見解

  • 病患自控鎮痛幫浦市場規模（2024 年）：3.854 億美元
  • 預計市場價值（2033 年）：7.12 億美元
  • 全球市場成長率（2024-2033 年複合年增長率）：7.1%

病人自控式止痛幫浦市場 - 研究範圍

患者自控鎮痛幫浦可讓患者在安全劑量範圍內自行給藥，在有效控制疼痛方面發揮重要作用。這些幫浦用於醫院、門診和家庭護理環境，以滿足患者在各種醫療條件下的不同需求，包括術後疼痛管理、慢性疼痛和安寧療護。

推動市場成長的因素：

患者自控鎮痛泵的全球市場是由幾個關鍵因素推動的，包括慢性疼痛疾病的流行、外科手術的增加以及對個性化疼痛管理解決方案的日益偏好。技術進步也促進了市場成長，例如更安全、更易於使用的智慧泵市場的發展。此外，控制醫療成本的努力以及由於患者便利而轉向門診和家庭護理的舉措進一步刺激了市場擴張。

市場限制因素：

儘管預計會有良好的成長，但患者自控鎮痛泵市場面臨著嚴格的監管要求、對用藥錯誤的擔憂以及先進泵技術的高成本等課題。在某些地區，這些設備的報銷範圍有限也對市場滲透構成障礙，特別是在新興經濟體。

市場機會：

由於給藥技術的進步、醫療保健支出的增加以及全球老年人口的擴大，患者自控鎮痛泵市場提供了巨大的成長機會。遠端監控和數據分析等數位健康解決方案的整合將改善患者治療結果和營運效率，推動市場成長。策略聯盟、合作夥伴關係以及研發投資對於在不斷變化的市場格局中利用新機會和保持競爭優勢至關重要。

本報告解決的關鍵問題

  • 推動病患自控鎮痛幫浦市場成長的關鍵因素是什麼？
  • 哪些類型的幫浦和應用正在推動其在各種醫療保健環境中的採用？
  • 技術進步如何改變病人自控式鎮痛幫浦市場的競爭格局？
  • 誰是對市場做出貢獻的主要參與者？ 他們採取了哪些策略來維持市場影響力？
  • 全球病人自控鎮痛幫浦市場的新趨勢與未來前景如何？

目錄

第1章 摘要整理

第2章 市場概要

  • 市場範圍/分類
  • 市場定義/範圍/限制

第3章 市場背景

  • 市場動態
  • 情勢預測
  • 機會地圖分析
  • 產品生命週期分析
  • 供應鏈分析
  • 投資可行性矩陣
  • 價值鏈分析
  • PESTLE和波特五力分析
  • 法規情形
  • 地區親市場預測
  • 生產·消費統計
  • 進口和出口的統計

第4章 病患自控鎮痛幫浦的全球市場分析

  • 過去的市場規模金額(一百萬美元)數量(單位)分析，2019年～2023年
  • 現在及未來市場規模，金額(一百萬美元)和數量(單位)的預測，2024年～2033年
    • 與前一年同期比較成長趨勢分析
    • 絕對額的機會分析

第5章 病患自控鎮痛幫浦的全球市場分析:各類型

  • 簡介/主要調查結果
  • 過去的市場規模金額(一百萬美元)和數量(單位)的分析:各類型，2019年～2023年
  • 現在及未來市場規模金額(一百萬美元)和數量(單位)的分析與預測:各類型，2024年～2033年
    • 電子
    • 機器
  • 與前一年同期比較成長趨勢分析:各類型，2019年～2023年
  • 絕對額的機會分析:各類型，2024年～2033年

第6章 病患自控鎮痛幫浦的全球市場分析:各用途

  • 簡介/主要調查結果
  • 過去的市場規模金額(一百萬美元)和數量(單位)的分析:各用途，2019年～2023年
  • 現在及未來市場規模金額(一百萬美元)和數量(單位)的分析與預測:各用途，2024年～2033年
    • 糖尿病
    • 腫瘤學
    • 消化器官內科
    • 血液學
    • 其他的用途
  • 與前一年同期比較成長趨勢分析:各用途，2019年～2023年
  • 絕對額的機會分析:各用途，2024年～2033年

第7章 病患自控鎮痛幫浦的全球市場分析:各最終用途

  • 簡介/主要調查結果
  • 過去的市場規模金額(一百萬美元)和數量(單位)的分析:各最終用途，2019年～2023年
  • 現在及未來市場規模金額(一百萬美元)和數量(單位)的分析與預測:各最終用途，2024年～2033年
    • 醫院
    • 專門診所
    • 門診病人手術中心
    • 居家照護設定
  • 與前一年同期比較成長趨勢分析:各最終用途，2019年～2023年
  • 絕對額的機會分析:各最終用途，2024年～2033年

第8章 病患自控鎮痛幫浦的全球市場分析:各地區

  • 簡介
  • 過去的市場規模(一百萬美元)和數量(單位)的分析:各地區，2019年～2023年
  • 目前市場規模金額(一百萬美元)和數量(單位)的分析與預測:各地區，2024年～2033年
    • 北美
    • 南美
    • 歐洲
    • 亞太地區
    • 中東·非洲
  • 市場魅力分析:各地區

第9章 北美的病患自控鎮痛幫浦市場分析:各國

第10章 南美的病患自控鎮痛幫浦市場分析:各國

第11章 歐洲的病患自控鎮痛幫浦市場分析:各國

第12章 亞太地區的病患自控鎮痛幫浦市場分析:各國

第13章 中東·非洲病患自控鎮痛幫浦市場分析:各國

第14章 主要國家的病患自控鎮痛幫浦市場分析

  • 金額(一百萬美元)和數量(單位)
  • 加拿大
  • 巴西
  • 墨西哥
  • 德國
  • 英國
  • 法國
  • 西班牙
  • 義大利
  • 俄羅斯
  • 中國
  • 日本
  • 印度
  • 韓國
  • 澳洲
  • 南非
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國
  • 以色列

第15章 市場結構分析

  • 競爭儀表板
  • 競爭基準
  • 主要企業的市場佔有率分析

第16章 競爭分析

  • 競爭的詳細資訊
    • Smiths Group plc
    • Fresenius SE &Co KGaA
    • B. Braun Melsungen AG
    • Baxter International Inc.
    • Becton, Dickinson and Company
    • ICU Medical, Inc.
    • ACE Medical
    • Terumo Corporation
    • Pfizer Inc

第17章 所使用的前提條件與縮寫

第18章 調查手法

簡介目錄
Product Code: PMRREP33269

Persistence Market Research has recently released a comprehensive report on the Patient-controlled Analgesic Pumps Market. The report offers a thorough assessment of crucial market dynamics, including drivers, trends, opportunities, and challenges, providing detailed insights into the market structure.

Key Insights:

  • Patient-controlled Analgesic Pumps Market Size (2024E): USD 385.4 million
  • Projected Market Value (2033F): USD 712 million
  • Global Market Growth Rate (CAGR 2024 to 2033): 7.1%

Patient-controlled Analgesic Pumps Market - Report Scope:

Patient-controlled analgesic pumps play a crucial role in managing pain effectively by allowing patients to self-administer medications within safe dosage limits. These pumps are utilized in hospitals, outpatient settings, and homecare environments, catering to diverse patient needs across various medical conditions, including post-operative pain management, chronic pain, and palliative care.

Market Growth Drivers:

The global patient-controlled analgesic pumps market is propelled by several key factors, including the growing prevalence of chronic pain conditions, increasing surgical procedures, and the rising preference for personalized pain management solutions. Technological advancements, such as the development of smart pumps with enhanced safety features and usability, are also contributing to market growth. Moreover, the shift towards outpatient and home-based care settings, driven by healthcare cost containment efforts and patient convenience, further stimulates market expansion.

Market Restraints:

Despite promising growth prospects, the patient-controlled analgesic pumps market faces challenges related to stringent regulatory requirements, concerns over medication errors, and the high cost of advanced pump technologies. Limited reimbursement coverage for these devices in some regions also poses barriers to market penetration, particularly in emerging economies.

Market Opportunities:

The patient-controlled analgesic pumps market presents significant growth opportunities driven by advancements in drug delivery technologies, increasing healthcare expenditure, and the expanding elderly population globally. The integration of digital health solutions, such as remote monitoring and data analytics, enhances patient outcomes and operational efficiencies, fostering market growth. Strategic collaborations, partnerships, and investments in research and development are crucial for capitalizing on emerging opportunities and maintaining competitive advantage in the evolving market landscape.

Key Questions Answered in the Report:

  • What are the primary factors driving the growth of the patient-controlled analgesic pumps market globally?
  • Which pump types and applications are driving adoption across different healthcare settings?
  • How are technological advancements reshaping the competitive landscape of the patient-controlled analgesic pumps market?
  • Who are the key players contributing to the market, and what strategies are they employing to maintain market relevance?
  • What are the emerging trends and future prospects in the global patient-controlled analgesic pumps market?

Competitive Intelligence and Business Strategy:

Leading players in the global patient-controlled analgesic pumps market, including Smiths Group plc.,Fresenius Kabi Group,

Hospira, focus on innovation, product differentiation, and strategic partnerships to gain a competitive edge. These companies invest in research and development to introduce advanced pump technologies, enhance user interface design, and improve patient safety features. Collaboration with healthcare providers, regulatory agencies, and patient advocacy groups facilitates market access and supports regulatory compliance. Moreover, emphasis on patient education, training programs, and clinical support services enhances market penetration and promotes safe and effective pain management practices.

Key Companies Profiled:

  • Smiths Group plc.
  • Fresenius Kabi Group
  • Hospira
  • Micrel Medical Devices,
  • Ace Medical Co. Ltd.
  • Terumo Corporation
  • B.Braun Melsungen AG
  • Baxter International
  • Becton Dickinson and Company
  • ICU Medical

Market Segments Covered in Patient-controlled Analgesic Pumps Market Analysis

By End Use

  • Hospitals
  • Specialty Clinics
  • Ambulatory Surgical Centers
  • Home Care Settings

By Type

  • Electronic
  • Mechanical

By Application

  • Diabetes
  • Oncology
  • Gastroenterology
  • Hematology
  • Other Applications

By Region

  • North America
  • Latin America
  • Europe
  • APAC
  • MEA

Table of Contents

1. Executive Summary

  • 1.1. Global Market Outlook
  • 1.2. Demand-side Trends
  • 1.3. Supply-side Trends
  • 1.4. Technology Roadmap Analysis
  • 1.5. Analysis and Recommendations

2. Market Overview

  • 2.1. Market Coverage / Taxonomy
  • 2.2. Market Definition / Scope / Limitations

3. Market Background

  • 3.1. Market Dynamics
    • 3.1.1. Drivers
    • 3.1.2. Restraints
    • 3.1.3. Opportunity
    • 3.1.4. Trends
  • 3.2. Scenario Forecast
    • 3.2.1. Demand in Optimistic Scenario
    • 3.2.2. Demand in Likely Scenario
    • 3.2.3. Demand in Conservative Scenario
  • 3.3. Opportunity Map Analysis
  • 3.4. Product Life Cycle Analysis
  • 3.5. Supply Chain Analysis
    • 3.5.1. Supply Side Participants and their Roles
      • 3.5.1.1. Producers
      • 3.5.1.2. Mid-Level Participants (Traders/ Agents/ Brokers)
      • 3.5.1.3. Wholesalers and Distributors
    • 3.5.2. Value Added and Value Created at Node in the Supply Chain
    • 3.5.3. List of Raw Material Suppliers
    • 3.5.4. List of Existing and Potential Buyer's
  • 3.6. Investment Feasibility Matrix
  • 3.7. Value Chain Analysis
    • 3.7.1. Profit Margin Analysis
    • 3.7.2. Wholesalers and Distributors
    • 3.7.3. Retailers
  • 3.8. PESTLE and Porter's Analysis
  • 3.9. Regulatory Landscape
    • 3.9.1. By Key Regions
    • 3.9.2. By Key Countries
  • 3.10. Regional Parent Market Outlook
  • 3.11. Production and Consumption Statistics
  • 3.12. Import and Export Statistics

4. Global Patient-controlled Analgesic Pumps Market Analysis 2019-2023 and Forecast, 2024-2033

  • 4.1. Historical Market Size Value (US$ Mn) & Volume (Units) Analysis, 2019-2023
  • 4.2. Current and Future Market Size Value (US$ Mn) & Volume (Units) Projections, 2024-2033
    • 4.2.1. Y-o-Y Growth Trend Analysis
    • 4.2.2. Absolute $ Opportunity Analysis

5. Global Patient-controlled Analgesic Pumps Market Analysis 2019-2023 and Forecast 2024-2033, By Type

  • 5.1. Introduction / Key Findings
  • 5.2. Historical Market Size Value (US$ Mn) & Volume (Units) Analysis By Type, 2019-2023
  • 5.3. Current and Future Market Size Value (US$ Mn) & Volume (Units) Analysis and Forecast By Type, 2024-2033
    • 5.3.1. Electronic
    • 5.3.2. Mechanical
  • 5.4. Y-o-Y Growth Trend Analysis By Type, 2019-2023
  • 5.5. Absolute $ Opportunity Analysis By Type, 2024-2033

6. Global Patient-controlled Analgesic Pumps Market Analysis 2019-2023 and Forecast 2024-2033, By Application

  • 6.1. Introduction / Key Findings
  • 6.2. Historical Market Size Value (US$ Mn) & Volume (Units) Analysis By Application, 2019-2023
  • 6.3. Current and Future Market Size Value (US$ Mn) & Volume (Units) Analysis and Forecast By Application, 2024-2033
    • 6.3.1. Diabetes
    • 6.3.2. Oncology
    • 6.3.3. Gastroenterology
    • 6.3.4. Hematology
    • 6.3.5. Other Applications
  • 6.4. Y-o-Y Growth Trend Analysis By Application, 2019-2023
  • 6.5. Absolute $ Opportunity Analysis By Application, 2024-2033

7. Global Patient-controlled Analgesic Pumps Market Analysis 2019-2023 and Forecast 2024-2033, By End-use

  • 7.1. Introduction / Key Findings
  • 7.2. Historical Market Size Value (US$ Mn) & Volume (Units) Analysis By End-use, 2019-2023
  • 7.3. Current and Future Market Size Value (US$ Mn) & Volume (Units) Analysis and Forecast By End-use, 2024-2033
    • 7.3.1. Hospitals
    • 7.3.2. Specialty Clinics
    • 7.3.3. Ambulatory Surgical Centers
    • 7.3.4. Home Care Settings
  • 7.4. Y-o-Y Growth Trend Analysis By End-use, 2019-2023
  • 7.5. Absolute $ Opportunity Analysis By End-use, 2024-2033

8. Global Patient-controlled Analgesic Pumps Market Analysis 2019-2023 and Forecast 2024-2033, By Region

  • 8.1. Introduction
  • 8.2. Historical Market Size Value (US$ Mn) & Volume (Units) Analysis By Region, 2019-2023
  • 8.3. Current Market Size Value (US$ Mn) & Volume (Units) Analysis and Forecast By Region, 2024-2033
    • 8.3.1. North America
    • 8.3.2. Latin America
    • 8.3.3. Europe
    • 8.3.4. Asia Pacific
    • 8.3.5. MEA
  • 8.4. Market Attractiveness Analysis By Region

9. North America Patient-controlled Analgesic Pumps Market Analysis 2019-2023 and Forecast 2024-2033, By Country

  • 9.1. Historical Market Size Value (US$ Mn) & Volume (Units) Trend Analysis By Market Taxonomy, 2019-2023
  • 9.2. Market Size Value (US$ Mn) & Volume (Units) Forecast By Market Taxonomy, 2024-2033
    • 9.2.1. By Country
      • 9.2.1.1. Value (US$ Mn) & Volume (Units)ed States
      • 9.2.1.2. Canada
    • 9.2.2. By Type
    • 9.2.3. By Application
    • 9.2.4. By End-use
  • 9.3. Market Attractiveness Analysis
    • 9.3.1. By Country
    • 9.3.2. By Type
    • 9.3.3. By Application
    • 9.3.4. By End-use
  • 9.4. Key Takeaways

10. Latin America Patient-controlled Analgesic Pumps Market Analysis 2019-2023 and Forecast 2024-2033, By Country

  • 10.1. Historical Market Size Value (US$ Mn) & Volume (Units) Trend Analysis By Market Taxonomy, 2019-2023
  • 10.2. Market Size Value (US$ Mn) & Volume (Units) Forecast By Market Taxonomy, 2024-2033
    • 10.2.1. By Country
      • 10.2.1.1. Brazil
      • 10.2.1.2. Mexico
      • 10.2.1.3. Rest of Latin America
    • 10.2.2. By Type
    • 10.2.3. By Application
    • 10.2.4. By End-use
  • 10.3. Market Attractiveness Analysis
    • 10.3.1. By Country
    • 10.3.2. By Type
    • 10.3.3. By Application
    • 10.3.4. By End-use
  • 10.4. Key Takeaways

11. Europe Patient-controlled Analgesic Pumps Market Analysis 2019-2023 and Forecast 2024-2033, By Country

  • 11.1. Historical Market Size Value (US$ Mn) & Volume (Units) Trend Analysis By Market Taxonomy, 2019-2023
  • 11.2. Market Size Value (US$ Mn) & Volume (Units) Forecast By Market Taxonomy, 2024-2033
    • 11.2.1. By Country
      • 11.2.1.1. Germany
      • 11.2.1.2. U.K.
      • 11.2.1.3. France
      • 11.2.1.4. Spain
      • 11.2.1.5. Italy
      • 11.2.1.6. Russia
      • 11.2.1.7. Rest of Europe
    • 11.2.2. By Type
    • 11.2.3. By Application
    • 11.2.4. By End-use
  • 11.3. Market Attractiveness Analysis
    • 11.3.1. By Country
    • 11.3.2. By Type
    • 11.3.3. By Application
    • 11.3.4. By End-use
  • 11.4. Key Takeaways

12. Asia Pacific Patient-controlled Analgesic Pumps Market Analysis 2019-2023 and Forecast 2024-2033, By Country

  • 12.1. Historical Market Size Value (US$ Mn) & Volume (Units) Trend Analysis By Market Taxonomy, 2019-2023
  • 12.2. Market Size Value (US$ Mn) & Volume (Units) Forecast By Market Taxonomy, 2024-2033
    • 12.2.1. By Country
      • 12.2.1.1. China
      • 12.2.1.2. Japan
      • 12.2.1.3. India
      • 12.2.1.4. South Korea
      • 12.2.1.5. Australia
      • 12.2.1.6. Rest of APAC
    • 12.2.2. By Type
    • 12.2.3. By Application
    • 12.2.4. By End-use
  • 12.3. Market Attractiveness Analysis
    • 12.3.1. By Country
    • 12.3.2. By Type
    • 12.3.3. By Application
    • 12.3.4. By End-use
  • 12.4. Key Takeaways

13. MEA Patient-controlled Analgesic Pumps Market Analysis 2019-2023 and Forecast 2024-2033, By Country

  • 13.1. Historical Market Size Value (US$ Mn) & Volume (Units) Trend Analysis By Market Taxonomy, 2019-2023
  • 13.2. Market Size Value (US$ Mn) & Volume (Units) Forecast By Market Taxonomy, 2024-2033
    • 13.2.1. By Country
      • 13.2.1.1. South Africa
      • 13.2.1.2. Saudi Arabia
      • 13.2.1.3. UAE
      • 13.2.1.4. Israel
      • 13.2.1.5. Rest of MEA
    • 13.2.2. By Type
    • 13.2.3. By Application
    • 13.2.4. By End-use
  • 13.3. Market Attractiveness Analysis
    • 13.3.1. By Country
    • 13.3.2. By Type
    • 13.3.3. By Application
    • 13.3.4. By End-use
  • 13.4. Key Takeaways

14. Key Countries Patient-controlled Analgesic Pumps Market Analysis

  • 14.1. Value (US$ Mn) & Volume (Units)ed States
    • 14.1.1. Pricing Analysis
    • 14.1.2. Market Share Analysis, 2024
      • 14.1.2.1. By Type
      • 14.1.2.2. By Application
      • 14.1.2.3. By End-use
  • 14.2. Canada
    • 14.2.1. Pricing Analysis
    • 14.2.2. Market Share Analysis, 2024
      • 14.2.2.1. By Type
      • 14.2.2.2. By Application
      • 14.2.2.3. By End-use
  • 14.3. Brazil
    • 14.3.1. Pricing Analysis
    • 14.3.2. Market Share Analysis, 2024
      • 14.3.2.1. By Type
      • 14.3.2.2. By Application
      • 14.3.2.3. By End-use
  • 14.4. Mexico
    • 14.4.1. Pricing Analysis
    • 14.4.2. Market Share Analysis, 2024
      • 14.4.2.1. By Type
      • 14.4.2.2. By Application
      • 14.4.2.3. By End-use
  • 14.5. Germany
    • 14.5.1. Pricing Analysis
    • 14.5.2. Market Share Analysis, 2024
      • 14.5.2.1. By Type
      • 14.5.2.2. By Application
      • 14.5.2.3. By End-use
  • 14.6. U.K.
    • 14.6.1. Pricing Analysis
    • 14.6.2. Market Share Analysis, 2024
      • 14.6.2.1. By Type
      • 14.6.2.2. By Application
      • 14.6.2.3. By End-use
  • 14.7. France
    • 14.7.1. Pricing Analysis
    • 14.7.2. Market Share Analysis, 2024
      • 14.7.2.1. By Type
      • 14.7.2.2. By Application
      • 14.7.2.3. By End-use
  • 14.8. Spain
    • 14.8.1. Pricing Analysis
    • 14.8.2. Market Share Analysis, 2024
      • 14.8.2.1. By Type
      • 14.8.2.2. By Application
      • 14.8.2.3. By End-use
  • 14.9. Italy
    • 14.9.1. Pricing Analysis
    • 14.9.2. Market Share Analysis, 2024
      • 14.9.2.1. By Type
      • 14.9.2.2. By Application
      • 14.9.2.3. By End-use
  • 14.10. Russia
    • 14.10.1. Pricing Analysis
    • 14.10.2. Market Share Analysis, 2024
      • 14.10.2.1. By Type
      • 14.10.2.2. By Application
      • 14.10.2.3. By End-use
  • 14.11. China
    • 14.11.1. Pricing Analysis
    • 14.11.2. Market Share Analysis, 2024
      • 14.11.2.1. By Type
      • 14.11.2.2. By Application
      • 14.11.2.3. By End-use
  • 14.12. Japan
    • 14.12.1. Pricing Analysis
    • 14.12.2. Market Share Analysis, 2024
      • 14.12.2.1. By Type
      • 14.12.2.2. By Application
      • 14.12.2.3. By End-use
  • 14.13. India
    • 14.13.1. Pricing Analysis
    • 14.13.2. Market Share Analysis, 2024
      • 14.13.2.1. By Type
      • 14.13.2.2. By Application
      • 14.13.2.3. By End-use
  • 14.14. South Korea
    • 14.14.1. Pricing Analysis
    • 14.14.2. Market Share Analysis, 2024
      • 14.14.2.1. By Type
      • 14.14.2.2. By Application
      • 14.14.2.3. By End-use
  • 14.15. Australia
    • 14.15.1. Pricing Analysis
    • 14.15.2. Market Share Analysis, 2024
      • 14.15.2.1. By Type
      • 14.15.2.2. By Application
      • 14.15.2.3. By End-use
  • 14.16. South Africa
    • 14.16.1. Pricing Analysis
    • 14.16.2. Market Share Analysis, 2024
      • 14.16.2.1. By Type
      • 14.16.2.2. By Application
      • 14.16.2.3. By End-use
  • 14.17. Saudi Arabia
    • 14.17.1. Pricing Analysis
    • 14.17.2. Market Share Analysis, 2024
      • 14.17.2.1. By Type
      • 14.17.2.2. By Application
      • 14.17.2.3. By End-use
  • 14.18. UAE
    • 14.18.1. Pricing Analysis
    • 14.18.2. Market Share Analysis, 2024
      • 14.18.2.1. By Type
      • 14.18.2.2. By Application
      • 14.18.2.3. By End-use
  • 14.19. Israel
    • 14.19.1. Pricing Analysis
    • 14.19.2. Market Share Analysis, 2024
      • 14.19.2.1. By Type
      • 14.19.2.2. By Application
      • 14.19.2.3. By End-use

15. Market Structure Analysis

  • 15.1. Competition Dashboard
  • 15.2. Competition Benchmarking
  • 15.3. Market Share Analysis of Top Players
    • 15.3.1. By Regional
    • 15.3.2. By Type
    • 15.3.3. By Application
    • 15.3.4. By End-use

16. Competition Analysis

  • 16.1. Competition Deep Dive
    • 16.1.1. Smiths Group plc
      • 16.1.1.1. Overview
      • 16.1.1.2. Product Portfolio
      • 16.1.1.3. Profitability by Market Segments
      • 16.1.1.4. Sales Footprint
      • 16.1.1.5. Strategy Overview
        • 16.1.1.5.1. Marketing Strategy
        • 16.1.1.5.2. Product Strategy
        • 16.1.1.5.3. Channel Strategy
    • 16.1.2. Fresenius SE & Co KGaA
      • 16.1.2.1. Overview
      • 16.1.2.2. Product Portfolio
      • 16.1.2.3. Profitability by Market Segments
      • 16.1.2.4. Sales Footprint
      • 16.1.2.5. Strategy Overview
        • 16.1.2.5.1. Marketing Strategy
        • 16.1.2.5.2. Product Strategy
        • 16.1.2.5.3. Channel Strategy
    • 16.1.3. B. Braun Melsungen AG
      • 16.1.3.1. Overview
      • 16.1.3.2. Product Portfolio
      • 16.1.3.3. Profitability by Market Segments
      • 16.1.3.4. Sales Footprint
      • 16.1.3.5. Strategy Overview
        • 16.1.3.5.1. Marketing Strategy
        • 16.1.3.5.2. Product Strategy
        • 16.1.3.5.3. Channel Strategy
    • 16.1.4. Baxter International Inc.
      • 16.1.4.1. Overview
      • 16.1.4.2. Product Portfolio
      • 16.1.4.3. Profitability by Market Segments
      • 16.1.4.4. Sales Footprint
      • 16.1.4.5. Strategy Overview
        • 16.1.4.5.1. Marketing Strategy
        • 16.1.4.5.2. Product Strategy
        • 16.1.4.5.3. Channel Strategy
    • 16.1.5. Becton, Dickinson and Company
      • 16.1.5.1. Overview
      • 16.1.5.2. Product Portfolio
      • 16.1.5.3. Profitability by Market Segments
      • 16.1.5.4. Sales Footprint
      • 16.1.5.5. Strategy Overview
        • 16.1.5.5.1. Marketing Strategy
        • 16.1.5.5.2. Product Strategy
        • 16.1.5.5.3. Channel Strategy
    • 16.1.6. ICU Medical, Inc.
      • 16.1.6.1. Overview
      • 16.1.6.2. Product Portfolio
      • 16.1.6.3. Profitability by Market Segments
      • 16.1.6.4. Sales Footprint
      • 16.1.6.5. Strategy Overview
        • 16.1.6.5.1. Marketing Strategy
        • 16.1.6.5.2. Product Strategy
        • 16.1.6.5.3. Channel Strategy
    • 16.1.7. ACE Medical
      • 16.1.7.1. Overview
      • 16.1.7.2. Product Portfolio
      • 16.1.7.3. Profitability by Market Segments
      • 16.1.7.4. Sales Footprint
      • 16.1.7.5. Strategy Overview
        • 16.1.7.5.1. Marketing Strategy
        • 16.1.7.5.2. Product Strategy
        • 16.1.7.5.3. Channel Strategy
    • 16.1.8. Terumo Corporation
      • 16.1.8.1. Overview
      • 16.1.8.2. Product Portfolio
      • 16.1.8.3. Profitability by Market Segments
      • 16.1.8.4. Sales Footprint
      • 16.1.8.5. Strategy Overview
        • 16.1.8.5.1. Marketing Strategy
        • 16.1.8.5.2. Product Strategy
        • 16.1.8.5.3. Channel Strategy
    • 16.1.9. Pfizer Inc
      • 16.1.9.1. Overview
      • 16.1.9.2. Product Portfolio
      • 16.1.9.3. Profitability by Market Segments
      • 16.1.9.4. Sales Footprint
      • 16.1.9.5. Strategy Overview
        • 16.1.9.5.1. Marketing Strategy
        • 16.1.9.5.2. Product Strategy
        • 16.1.9.5.3. Channel Strategy

17. Assumptions & Acronyms Used

18. Research Methodology